Tyra Biosciences 주식 가격. TYRA - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

14.65

매수가

14.11

매도가

17.60

거래량

146,750

14.60 일간 변동폭 15.52

12.485 52주 범위 29.60

market_cap

741.334M

전일 종가

15.39

개장가

15.38

최근 거래 시간

476

14.65

(priorref)

마지막 거래 시간

06:08:12

재정 규모

US$ 2,180,623

VWAP

14.8594

평균 볼륨(3m)

244,004

발행 주식

50,602,991

배당수익률

주가수익률

-10.73

주당순이익(EPS)

-1.37

매출

순이익

-69.13M

Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer.

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.tyra.bio

본부

Wilmington, Delaware, USA

설립됨

Tyra Biosciences Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker TYRA. The last closing price for Tyra Biosciences was US$15.39. Over the last year, Tyra Biosciences shares have traded in a share price range of US$ 12.485 to US$ 29.60.

Tyra Biosciences currently has 50,602,991 shares in issue. The market capitalisation of Tyra Biosciences is US$778.78 million. Tyra Biosciences has a price to earnings ratio (PE ratio) of -10.73.

Form 8-K - Current report

Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors

Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors PR Newswire CARLSBAD, Calif., Jan. 29, 2025 CARLSBAD, Calif., Jan. 29, 2025 /PRNewswire/ -- Tyra Biosciences, Inc...

Form 144 - Report of proposed sale of securities

Tyra Biosciences Announces Poster Presentations at 2025 ASCO Gastrointestinal Cancers Symposium

Tyra Biosciences Announces Poster Presentations at 2025 ASCO Gastrointestinal Cancers Symposium PR Newswire CARLSBAD, Calif., Jan. 22, 2025 CARLSBAD, Calif., Jan. 22, 2025 /PRNewswire/ -- Tyra...

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302) PR Newswire CARLSBAD, Calif., Jan. 10, 2025 -TYRA...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-1.05	-6.68789808917	15.7	16.45	14.65	171303	15.64797509	CS
4	0.59	4.19630156472	14.06	17.27	14.06	265617	15.78771258	CS
12	-2.11	-12.5894988067	16.76	17.78	13.2705	244004	15.62165372	CS
26	-5.44	-27.0781483325	20.09	29.6	13.2705	263801	18.94423094	CS
52	1.7	13.1274131274	12.95	29.6	12.485	203059	18.51987009	CS
156	2.63	21.8801996672	12.02	29.6	4.93	110294	15.8953325	CS
260	-15.25	-51.0033444816	29.9	31.36	4.93	127336	16.24573828	CS

TYRA - Frequently Asked Questions (FAQ)

What is the current Tyra Biosciences share price?

The current share price of Tyra Biosciences is US$ 14.65

How many Tyra Biosciences shares are in issue?

Tyra Biosciences has 50,602,991 shares in issue

What is the market cap of Tyra Biosciences?

The market capitalisation of Tyra Biosciences is USD 778.78M

What is the 1 year trading range for Tyra Biosciences share price?

Tyra Biosciences has traded in the range of US$ 12.485 to US$ 29.60 during the past year

What is the PE ratio of Tyra Biosciences?

The price to earnings ratio of Tyra Biosciences is -10.73

What is the reporting currency for Tyra Biosciences?

Tyra Biosciences reports financial results in USD

What is the latest annual profit for Tyra Biosciences?

The latest annual profit of Tyra Biosciences is USD -69.13M

What is the registered address of Tyra Biosciences?

The registered address for Tyra Biosciences is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Tyra Biosciences website address?

The website address for Tyra Biosciences is www.tyra.bio

Which industry sector does Tyra Biosciences operate in?

Tyra Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
CARMCarisma Therapeutics Inc	US$ 0.6734 (33.45%)	438.4k
EDSAEdesa Biotech Inc	US$ 2.21 (20.79%)	815
OSTOstin Technology Group Company Ltd	US$ 3.43 (18.10%)	49.53k
IVAInventiva SA	US$ 2.6501 (15.22%)	749
IFBDInfobird Company Ltd	US$ 2.45 (12.90%)	105.91k
DOMHDominari Holdings Inc	US$ 2.0201 (-11.01%)	533
DGNXDiginex Ltd	US$ 45.00 (-8.50%)	52.02k
XFORX4 Pharmaceuticals Inc	US$ 0.6912 (-8.35%)	350k
CTXRCitius Pharmaceuticals Inc	US$ 2.53 (-8.33%)	921
MSFUDirexion Daily MSFT Bull 2X ETF	US$ 39.61 (-7.95%)	51.6k
NVDANVIDIA Corporation	US$ 123.19 (-0.49%)	19.94M
VCSHVanguard Short Term Corporate Bond	US$ 78.43 (0.01%)	9.57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 23.2004 (-5.84%)	1.01M
MSFTMicrosoft Corporation	US$ 425.93 (-3.58%)	824.15k
TSLATesla Inc	US$ 377.55 (-2.70%)	776.92k